JENNIFER SCOTT: Open Payments
NPI 1215552898 · TERRE HAUTE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,564 in 153 payments from 20 companies in 2025. Trend: 2023 $2,014 · 2024 $1,638 · 2025 $2,564
Food & beverage: $2,464Education: $100
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 17 | $352 |
| Vanda Pharmaceuticals Inc. | 16 | $309 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 15 | $213 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $201 |
| Otsuka America Pharmaceutical, Inc. | 16 | $200 |
| Axsome Therapeutics, Inc. | 9 | $200 |
| Lundbeck LLC | 10 | $198 |
| Neurocrine BioSciences, Inc. | 11 | $164 |
| Collegium Pharmaceutical, Inc. | 12 | $143 |
| Alkermes, Inc. | 11 | $138 |
Products named: FANAPT, REXULTI, CAPLYTA, Auvelity, AUSTEDO XR, ENTYVIO, INGREZZA, Jornay PM.
Industry payments across IN — which companies pay providers there.
